首页|对比增强乳腺X线摄影征象与肿块型乳腺癌不同分子分型的相关性

对比增强乳腺X线摄影征象与肿块型乳腺癌不同分子分型的相关性

扫码查看
目的 探讨对比增强乳腺X线摄影征象(CEM)与肿块型乳腺癌不同分子分型之间的相关性。方法 回顾性收集2018年2月~2021年12月于我院就诊并经手术病理证实的220例肿块型乳腺癌患者的临床、病理及影像资料。所有患者术前均行CEM检查,并根据免疫组化将患者分为Luminal A、Luminal B、HER2过表达型和三阴性型。参照CEM的影像诊断报告和数据系统(BI-RADS)分别提取患者低能图和减影图的影像学征象,包括肿块形态、边缘、强化程度等共11个特征,分析不同分子分型的乳腺癌与CEM-BI-RADS之间的关系。结果 共220例肿块型乳腺癌患者,包括Luminal A型50例,Luminal B型128例,HER2过表达型15例,三阴性型27例。在不同分子分型的乳腺癌临床病理特征中,仅病理类型与乳腺癌分子分型之间差异具有统计意义(P=0。012),4种乳腺癌分子分型病理类型均以浸润性乳腺癌为主,年龄、是否绝经及有无淋巴结转移均与乳腺癌分子分型之间无统计学意义(P>0。05)。低能图中病灶肿块边缘、肿块是否伴有钙化在不同分子分型之间的差异有统计学意义(P<0。05)。Luminal A型乳腺癌肿块边缘多表现为毛刺(64。0%,32/50),其它乳腺癌分子分型肿块边缘则以模糊为主,其中大多数HER2过表达型乳腺癌(66。7%,10/15)肿块多伴随钙化。减影图中肿块长径、肿块强化的边缘、内部强化与乳腺癌分子分型之间差异具有统计学意义(P<0。05),大多数Luminal A型及Luminal B型乳腺癌的肿块长径≤2。0 cm,而HER2过表达型及三阴性乳腺癌肿块长径以3。1~5。0 cm最为常见。虽然4种分子分型肿块强化时边缘虽以模糊最为常见,且内部强化不均匀,但相比于其它分子分型的乳腺癌,部分三阴性乳腺癌肿块内部强化可表现为环形强化(22。2%,6/27)。结论 CEM上不同分子分型肿块型乳腺癌影像学征象具有一定的特征性,可在指导乳腺癌诊治及预后评估方面提供重要的参考价值。
Correlation between the contrast enhanced mammography signs and different molecular subtypes of mass breast cancer
Objective To investigate the correlation between the imaging of contrast-enhanced mammography(CEM)and different molecular subtypes of mass breast cancer.Methods The clinical,pathological and imaging data from 220 patients who were initially diagnosed with mass breast cancer were collected from February 2018 to December 2021.All patients underwent routine CEM before surgery,and were divided into Luminal A,Luminal B,HER2-enriched,and triple-negative subtype according to immunohistochemistry.According to the breast imaging report and data system(BI-RADS)of CEM,the imaging signs of patients with low energy images and subtraction images were extracted respectively,including 11 features such as tumor shape,margin and enhancement degree.Finally,the relationship between different molecular types and the signs of CEM-BI-RADS was analyzed.Results A total of 220 patients with breast cancer were diagnosed,including 50 patients with Luminal A,128 patients with Luminal B,15 patients with HER2-enriched,and 27 patients with triple-negative.Among the clinicopathologic characteristics of different molecular subtypes of breast cancer,only the pathological type and molecular subtype of breast cancer had statistical significance(P=0.012).Invasive breast cancer was the main pathological type of the four molecular types of breast cancer,and there was no significant statistical significance between age,menopause and lymph node metastasis and molecular subtype of breast cancer(P>0.05).In low-energy maps,there were statistically significant differences in mass margins and mass with calcification among different molecular subtypes.Luminal A breast cancer tumor margins were mostly spiculated(64.0%,32/50),while other breast cancer molecular subtypes were mostly indistinct,and most HER2-enriched breast cancer tumors(66.7%,10/15)were mostly accompanied by calcification.In subtraction images,there were statistically significant differences between the margin,length diameter,internal enhancement and molecular classification of breast cancer.The maximum diameter of Luminal A and Luminal B breast cancers is less than 2.0 cm,while the maximum diameter of HER2-enriched and triple-negative breast cancers is 3.1-5.0 cm.In addition,although the edges of the four molecular subtypes of tumor enhancement were most common with obscured edges and the internal enhancement was uneven,compared with other molecular subtypes of breast cancer,the internal enhancement of some triple-negative breast cancer tumors showed circular enhancement(22.2%,6/27).Conclusion The imaging signs of different molecular subtypes of mass breast cancer in CEM have certain characteristics,which can provide important reference value in guiding the diagnosis,treatment and prognosis evaluation of breast cancer.

mass breast cancermolecular subtypecontrast-enhanced mammography

马梦伟、汪思娜、曾辉、陈卫国、徐维敏

展开 >

南方医科大学南方医院影像诊断科,广东 广州 510515

肿块型乳腺癌 分子分型 对比增强乳腺X线摄影

2024

分子影像学杂志
南方医科大学

分子影像学杂志

CSTPCD
ISSN:1674-4500
年,卷(期):2024.47(12)